MyAverix Finance
US · Healthcare
Wayland Group Corp (MRRCF)
Drug Manufacturers - Specialty & Generic
Wayland Group Corp (MRRCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MRRCF
Wayland Group Corp (MRRCF) — FAQ
What is MRRCF's P/E ratio?
The price-to-earnings (P/E) ratio for Wayland Group Corp (MRRCF) is 18.00 (data as of 2026-03-24).
Does Wayland Group Corp pay a dividend?
Dividend yield is not available in the current snapshot for Wayland Group Corp (MRRCF). Check the MyAverix Finance app for the latest dividend data.
What sector is Wayland Group Corp in?
Wayland Group Corp (MRRCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MRRCF listed on?
MRRCF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.